POCI vs TECH · rev $19.1M vs P/E 65, rev $1.22B
Precision Optics Corporation, Inc. Common stock (POCI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Precision Optics Corporation, Inc. Common stock (POCI) is a medical instruments & supplies company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported POCI revenue for 2025-06-30 was $19.1M. Net income was -$5.8M. Revenue was down 0.1% from 2024-06-30 to 2025-06-30. POCI currently screens at market cap $63.4M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
POCI currently screens at market cap $63.4M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the POCI and TECH stock pages for the full models.
Not investment advice.